Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Mark K. OkiCFO | Achieve Life SciencesACHV | Open-market sale | 25/09/18 | 25/09/22 | 50,060 sh | $2.92 | $146,175.2 | −28.1% |
Achieve Life SciencesACHV | Open-market sale | 25/09/18 | 25/09/22 | 129,501 sh | $2.92 | $378,142.92 | −36.1% | |
Cindy JacobsPresident & CMO | Achieve Life SciencesACHV | Open-market sale | 25/09/04 | 25/09/08 | 27,629 sh | $2.77 | $76,532.33 | −19.3% |
Thomas Braxton KingDirector | Achieve Life SciencesACHV | Open-market sale | 25/09/04 | 25/09/08 | 139,858 sh | $2.77 | $387,406.66 | −30.7% |
Jerry WanPrincipal Accounting Officer | Achieve Life SciencesACHV | Open-market sale | 25/09/04 | 25/09/08 | 14,070 sh | $2.77 | $38,973.9 | −30.1% |
Jaime XinosChief Commercial Officer | Achieve Life SciencesACHV | Open-market sale | 25/09/04 | 25/09/08 | 20,854 sh | $2.77 | $57,765.58 | −21.9% |
Mark K. OkiCFO | Achieve Life SciencesACHV | Open-market buy | 25/03/17 | 25/03/19 | 10,000 sh | $2.89 | $28,900 | No record |
Richard Alistair StewartChieve Executive Officer | Achieve Life SciencesACHV | Open-market buy | 25/03/17 | 25/03/19 | 10,000 sh | $2.86 | $28,600 | +19.7% |
John BencichCEO | Achieve Life SciencesACHV | Open-market buy | 24/03/04 | 24/03/06 | 10,000 sh | $4.59 | $45,900 | +15.0% |
Richard Alistair StewartExecutive Chairman | Achieve Life SciencesACHV | Open-market buy | 24/03/04 | 24/03/06 | 10,000 sh | $4.59 | $45,900 | +35.1% |
John BencichCEO | Achieve Life SciencesACHV | Open-market buy | 23/05/30 | 23/06/01 | 5,000 sh | $5.50 | $27,500 | +8.1% |